Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. E. Cabozantinib *** > (*) USA Approval Date: 2016. 04.25>

---

previously received anti-angiogenic therapy


(*) USA Approval Date: 2016. 04.25>'s products
This section has no products